DuckWiseArchive › ABBV
ABBV trade ideas: every closed DuckWise idea on AbbVie Inc.
DuckWise has published 1 idea on AbbVie Inc. (ABBV, Stock) that has closed between October 2020 and November 2020. Each is listed below with the levels published before the position was taken and its result at close — 1 in profit, 0 at a loss.
| Opened | Closed | Side | Entry | Stop | Projection | Close | Result | Days |
|---|---|---|---|---|---|---|---|---|
| Oct 20, 2020 | Nov 23, 2020 | Long | 83.59 | — | 100 | 102.36 | +22.45% | 34 |
Prices in US dollars. Result is the price change from the published entry to the published close, before fees, taxes and slippage. How results are counted.
About AbbVie Inc.
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. Pays a dividend yield of 2.63% annually.
These are closed ideas, published for the record. They are general and impersonal research, not a recommendation to buy or sell ABBV or any other security.